Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Antibodies industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Novartis
F Hoffmann-La Roche
Bristol-Myers Squibb
AbbVie
Eli Lilly
Johnson & Johnson Services
Amgen
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Monoclonal antibodies
Polyclonal antibodies
Antibody drug conjugates
Application:
Antibody drug conjugates
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Antibodies Industry Overview
-
1.1.1 Antibodies Market Scope and Market Segments
-
1.1.2 Antibodies Industry Characteristics
-
1.1.3 Global and China Antibodies Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Antibodies Production Value and Growth Rate (2017-2028)
-
1.2 Global Antibodies Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Monoclonal antibodies
-
1.2.2 Polyclonal antibodies
-
1.2.3 Antibody drug conjugates
-
1.3 Global Antibodies Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Antibody drug conjugates
-
1.4 Market Analysis by Region
-
1.4.1 North America Antibodies Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Antibodies Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Antibodies Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Antibodies Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Antibodies Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Antibodies Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Antibodies Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Antibodies Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Antibodies Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Antibodies Industry Porter's Five Forces Model Analysis
-
2.2.3 Antibodies Industry PEST Analysis
-
2.3 Antibodies Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Antibodies Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Antibodies Industry
Chapter 3 Global and China Antibodies Market, by Manufacturer
-
3.1 Global and China Antibodies Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Antibodies Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Antibodies Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Antibodies Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Antibodies Market Top 3 Players
Chapter 4 Global and China Antibodies Market, by Type (2017-2028)
-
4.1 Antibodies Market Trend, by Type
-
4.2 Global Antibodies Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Antibodies Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Antibodies Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Antibodies Price Trend, by Type (2017-2028)
-
4.3 China Antibodies Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Antibodies Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Antibodies Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Antibodies Price Trend, by Type (2017-2028)
Chapter 5 Global and China Antibodies Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Antibodies Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Antibodies Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Antibodies Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Antibodies Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Antibodies Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Antibodies Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Antibodies Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Antibodies Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Antibodies Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Antibodies Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Antibodies Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Antibodies Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Antibodies Market Analysis
-
7.1 North America Antibodies Market, by Type
-
7.2 North America Antibodies Market, by Application
-
7.3 North America Antibodies Market Analysis and Forecast, by Country
-
7.3.1 United States Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Antibodies Market Analysis
-
8.1 Europe Antibodies Market, by Type
-
8.2 Europe Antibodies Market, by Application
-
8.3 Europe Antibodies Market Analysis and Forecast, by Country
-
8.3.1 Germany Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Antibodies Market Analysis
-
9.1 APAC Antibodies Market, by Type
-
9.2 APAC Antibodies Market, by Application
-
9.3 APAC Antibodies Market Analysis and Forecast, by Country
-
9.3.1 China Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Antibodies Market Analysis
-
10.1 Latin America, Middle East and Africa Antibodies Market, by Type
-
10.2 Latin America, Middle East and Africa Antibodies Market, by Application
-
10.3 Latin America, Middle East and Africa Antibodies Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Antibodies Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Antibodies Company Profiles
-
11.1 Novartis
-
11.1.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Novartis Antibodies Product Profiles, Application and Specification
-
11.1.3 Novartis Antibodies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 F Hoffmann-La Roche
-
11.2.1 F Hoffmann-La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 F Hoffmann-La Roche Antibodies Product Profiles, Application and Specification
-
11.2.3 F Hoffmann-La Roche Antibodies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Bristol-Myers Squibb
-
11.3.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Bristol-Myers Squibb Antibodies Product Profiles, Application and Specification
-
11.3.3 Bristol-Myers Squibb Antibodies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 AbbVie
-
11.4.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 AbbVie Antibodies Product Profiles, Application and Specification
-
11.4.3 AbbVie Antibodies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Eli Lilly
-
11.5.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Eli Lilly Antibodies Product Profiles, Application and Specification
-
11.5.3 Eli Lilly Antibodies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Johnson & Johnson Services
-
11.6.1 Johnson & Johnson Services Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Johnson & Johnson Services Antibodies Product Profiles, Application and Specification
-
11.6.3 Johnson & Johnson Services Antibodies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Amgen
-
11.7.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Amgen Antibodies Product Profiles, Application and Specification
-
11.7.3 Amgen Antibodies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Antibodies Industry Investment Prospect and Risk Assessment
-
12.1 Antibodies Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Antibodies Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure China Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure Global Antibodies Production Value and Growth Rate (2017-2028)
-
Figure China Antibodies Production Value and Growth Rate (2017-2028)
-
Figure Global Antibodies Market Size and Growth Rate of Monoclonal antibodies (2017-2028)
-
Figure Global Antibodies Market Size and Growth Rate of Polyclonal antibodies (2017-2028)
-
Figure Global Antibodies Market Size and Growth Rate of Antibody drug conjugates (2017-2028)
-
Figure Global Antibodies Market Size and Growth Rate of Antibody drug conjugates (2017-2028)
-
Figure North America Antibodies Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Antibodies Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Antibodies Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Antibodies Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Antibodies Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Antibodies Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Antibodies Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Antibodies Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Antibodies Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Antibodies Market Share, by Manufacturer in 2021
-
Figure Global and China Antibodies Market Share, by Manufacturer in 2022
-
Table Global Antibodies Sales Volume, by Type (2017-2028)
-
Table Global Antibodies Sales Volume Share, by Type (2017-2028)
-
Figure Global Antibodies Sales Volume Share, by Type (2017-2028)
-
Table Global Antibodies Sales Value, by Type (2017-2028)
-
Table Global Antibodies Sales Value Share, by Type (2017-2028)
-
Figure Global Antibodies Price Trend, by Type (2017-2028)
-
Table China Antibodies Sales Volume, by Type (2017-2028)
-
Table China Antibodies Sales Volume Share, by Type (2017-2028)
-
Figure China Antibodies Sales Volume Share, by Type (2017-2028)
-
Table China Antibodies Sales Value, by Type (2017-2028)
-
Table China Antibodies Sales Value Share, by Type (2017-2028)
-
Figure China Antibodies Price Trend, by Type (2017-2028)
-
Table Global Antibodies Sales Volume, by Application (2017-2028)
-
Table Global Antibodies Sales Volume Share, by Application (2017-2028)
-
Figure Global Antibodies Sales Volume Share, by Application (2017-2028)
-
Table Global Antibodies Sales Value, by Application (2017-2028)
-
Table Global Antibodies Sales Value Share, by Application (2017-2028)
-
Figure Global Antibodies Sales Value Share, by Application (2017-2028)
-
Table China Antibodies Sales Volume, by Application (2017-2028)
-
Table China Antibodies Sales Volume Share, by Application (2017-2028)
-
Figure China Antibodies Sales Volume Share, by Application (2017-2028)
-
Table China Antibodies Sales Value, by Application (2017-2028)
-
Table China Antibodies Sales Value Share, by Application (2017-2028)
-
Figure China Antibodies Sales Value Share, by Application (2017-2028)
-
Figure China Antibodies Production, Import, Consumption and Export (2017-2022)
-
Figure North America Antibodies Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Antibodies Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Antibodies Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Antibodies Production, Import, Consumption and Export (2017-2022)
-
Table North America Antibodies Sales Volume, by Type (2017-2028)
-
Table North America Antibodies Sales Volume Share, by Type (2017-2028)
-
Figure North America Antibodies Sales Volume Share, by Type (2017-2028)
-
Table North America Antibodies Sales Volume, by Application (2017-2028)
-
Table North America Antibodies Sales Volume Share, by Application (2017-2028)
-
Figure North America Antibodies Sales Volume Share, by Application (2017-2028)
-
Figure United States Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure United States Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure Canada Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Antibodies Sales Value and Growth Rate (2017-2028)
-
Table Europe Antibodies Sales Volume, by Type (2017-2028)
-
Table Europe Antibodies Sales Volume Share, by Type (2017-2028)
-
Figure Europe Antibodies Sales Volume Share, by Type (2017-2028)
-
Table Europe Antibodies Sales Volume, by Application (2017-2028)
-
Table Europe Antibodies Sales Volume Share, by Application (2017-2028)
-
Figure Europe Antibodies Sales Volume Share, by Application (2017-2028)
-
Figure Germany Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure UK Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure UK Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure France Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure France Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure Italy Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure Spain Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure Poland Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure Russia Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Antibodies Sales Value and Growth Rate (2017-2028)
-
Table APAC Antibodies Sales Volume, by Type (2017-2028)
-
Table APAC Antibodies Sales Volume Share, by Type (2017-2028)
-
Figure APAC Antibodies Sales Volume Share, by Type (2017-2028)
-
Table APAC Antibodies Sales Volume, by Application (2017-2028)
-
Table APAC Antibodies Sales Volume Share, by Application (2017-2028)
-
Figure APAC Antibodies Sales Volume Share, by Application (2017-2028)
-
Figure China Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure China Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure Japan Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure India Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure India Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Antibodies Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Antibodies Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Antibodies Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Antibodies Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Antibodies Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Antibodies Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Antibodies Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Antibodies Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Antibodies Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Antibodies Sales Value and Growth Rate (2017-2028)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Antibodies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table F Hoffmann-La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table F Hoffmann-La Roche Product Profiles, Application and Specification
-
Table F Hoffmann-La Roche Antibodies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bristol-Myers Squibb Product Profiles, Application and Specification
-
Table Bristol-Myers Squibb Antibodies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AbbVie Product Profiles, Application and Specification
-
Table AbbVie Antibodies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eli Lilly Product Profiles, Application and Specification
-
Table Eli Lilly Antibodies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Johnson & Johnson Services Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Johnson & Johnson Services Product Profiles, Application and Specification
-
Table Johnson & Johnson Services Antibodies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Antibodies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
